NCT04035031View on ClinicalTrials.gov

Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

November 12, 2020

Study Completion Date

November 12, 2020

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Forxiga 10mg

Forxiga™ 10mg, dapagliflozin 10mg, oral, once daily for 7 days (70 mg total)

DRUG

Placebo

Placebo tablets, starch, oral, once daily for 7 days (7 tablets total)

Trial Locations (1)

3010

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04035031 - Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes | Biotech Hunter | Biotech Hunter